VEGFA and ovarian cancer: Lymph node metastasis, creatinine clearance rate of ≤60 mL per minute, RBC count of ≤3.3×1012 per liter, and combination therapy with vascular endothelial growth factor inhibitors are independent risk factors for PARPi SHAEs in patients with ovarian cancer.